The California-based company, founded in 2011, is committed to providing electrophysiologists with innovative cryoablation catheters that create safe, continuous, transmural lesions to treat cardiac arrhythmias anywhere in the heart. Adagio Medical's cryoablation technology treats paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia, allowing electrophysiologists to make continuous transmural endocardial lesions anywhere in the heart. Adagio Medical is a privately held company and a Fjord Ventures portfolio company. For more information, visit their website or contact them via email.